MAPT and supranuclear palsy, progressive, 1: In samples from PSP patients, we observed significantly higher levels of total MAPT mRNA in tissue from the frontal cortex (p = 0.006) but not in the occipital cortex (which is free of neurofibrillary degeneration) (Fig. 4A).